Manufacturer of Controlled Substances; Notice of Registration; Rhodes Technologies, 75671 [2012-30785]
Download as PDF
<![CDATA[
75671
Federal Register / Vol. 77, No. 246 / Friday, December 21, 2012 / Notices
will be further synthesized to bulk
manufacture a synthetic THC (7370). No
other activity for this drug code is
authorized for this registration.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a), and
determined that the registration of
AMRI Rensselaer, Inc., to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated AMRI Rensselaer, Inc., to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: December 18, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
mstockstill on DSK4VPTVN1PROD with
Manufacturer of Controlled
Substances; Notice of Registration;
Rhodes Technologies
Jkt 229001
[FR Doc. 2012–30785 Filed 12–20–12; 8:45 am]
BILLING CODE 4410–09–P
Inc., to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems; verification
of the company’s compliance with state
and local laws; and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
Dated: December 14, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–30783 Filed 12–20–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
DEPARTMENT OF JUSTICE
Manufacturer of Controlled
Substances; Notice of Registration;
Euticals, Inc.
Drug Enforcement Administration
Drug
Manufacturer of Controlled
Substances; Notice of Registration;
Chemtos, LLC
By Notice dated July 30, 2012, and
published in the Federal Register on
August 7, 2012, 77 FR 47116, Chemtos,
LLC, 14101 W. Highway 290, Building
2000B, Austin, Texas 78737–9331, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Schedule
Drug
By Notice dated May 31, 2012, and
published in the Federal Register on
June 8, 2012, 77 FR 34072, Rhodes
Technologies, 498 Washington Street,
Coventry, Rhode Island 02816, made
application to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of morphine (9300),
a basic class of controlled substance
listed in schedule II.
The company plans to manufacture
the listed controlled substance in bulk
for conversion and sale to dosage form
manufacturers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a), and
determined that the registration of
Rhodes Technologies to manufacture
the listed basic class of controlled
substance is consistent with the public
interest at this time. DEA has
investigated Rhodes Technologies to
ensure that the company’s registration is
consistent with the public interest. The
18:28 Dec 20, 2012
Dated: December 14, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
By Notice dated August 17, 2012, and
published in the Federal Register on
August 29, 2012, 77 FR 52367, Euticals,
Inc., (formerly known as Archimica,
Inc.), 2460 W. Bennett Street,
Springfield, Missouri 65807–1229, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
[FR Doc. 2012–30780 Filed 12–20–12; 8:45 am]
VerDate Mar<15>2010
investigation has included inspection
and testing of the company’s physical
security systems; verification of the
company’s compliance with state and
local laws; and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic class of
controlled substance listed.
Gamma
Hydroxybutyric
Acid
(2010).
Amphetamine (1100) ....................
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
Phenylacetone (8501) ..................
Methadone Intermediate (9254) ...
Tapentadol (9780) ........................
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution and sale to its
customers.
With regards to amphetamine (1100),
the company plans to acquire the listed
controlled substance in bulk from a
domestic source in order to manufacture
other controlled substances in bulk for
distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a), and
determined that the registration of
Euticals, Inc., to manufacture the listed
basic classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated Euticals,
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
Schedule
I
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
Nabilone (7379) ............................
Phenylacetone (8501) ..................
Cocaine (9041) .............................
Codeine (9050) .............................
Etorphine HCL (9059) ..................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Ecgonine (9180) ...........................
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Levomethorphan (9210) ...............
Levorphanol (9220) ......................
Isomethadone (9226) ...................
Meperidine (9230) ........................
Meperidine-intermediate-A (9232)
Meperidine-intermediate-B (9233)
Meperidine-intermediate-C (9234)
Methadone (9250) ........................
Methadone intermediate (9254) ...
Morphine (9300) ...........................
Thebaine (9333) ...........................
Dihydroetorphine (9334) ...............
Levo-alphacetylmethadol (9648) ..
E:\FR\FM\21DEN1.SGM
21DEN1
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
]]>Agencies
[Federal Register Volume 77, Number 246 (Friday, December 21, 2012)]
[Notices]
[Page 75671]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-30785]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
Rhodes Technologies
By Notice dated May 31, 2012, and published in the Federal Register
on June 8, 2012, 77 FR 34072, Rhodes Technologies, 498 Washington
Street, Coventry, Rhode Island 02816, made application to the Drug
Enforcement Administration (DEA) to be registered as a bulk
manufacturer of morphine (9300), a basic class of controlled substance
listed in schedule II.
The company plans to manufacture the listed controlled substance in
bulk for conversion and sale to dosage form manufacturers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a), and determined that the registration
of Rhodes Technologies to manufacture the listed basic class of
controlled substance is consistent with the public interest at this
time. DEA has investigated Rhodes Technologies to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems; verification of the company's compliance
with state and local laws; and a review of the company's background and
history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic class of controlled substance listed.
Dated: December 14, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-30785 Filed 12-20-12; 8:45 am]
BILLING CODE 4410-09-P
